Harvard Researchers have shed light on the liver and kidneys after toxin exposure, using machine learning.
University of Gothenburg researchers were able to use artificial intelligence and conventional statistical methods to identify the most important indicators of elevated risk for cardiovascular disease and death.
The Carlsbad, CA-based company said the technology’s initial focus will be on resolving the significant unmet clinical need in minimally invasive lateral procedures, but it can and will be leveraged into multiple Alphatec surgical approaches.
Indiana University of Medicine researchers said the test can help identify biomarkers in the blood and could actually help in the fight against opioid abuse.
The Salt Lake City-based company said its Tria device is one of the first biopolymer heart valve platforms.
University of Wisconsin School of Medicine and Public Health Researchers are using positron emission tomography with 18F-fluorofuranylnorprogesterone to give better insight on hormonal therapies for the treatment of breast cancer.
The AdVance XP Male Sling System has been redesigned for ease of placement and improved stability, the company noted.
Duke University Medical Center researchers looked at data from 9,000 patients who underwent Cardiac Magnetic Resonance.
A team from Mayo Clinic has developed an online tracking tool that could help patients suffering from kidney stones determine if they will have future bouts with the condition.
The research behind the development of the test was supported by the National Institute of Allergy and Infectious Diseases, part of NIH.
University of Texas Engineers have developed a noninvasive way to simulate repairs to the heart's mitral valve allowing surgeons to provide patient-specific treatments.
A $100M joint venture is expected to improve access to advanced rehabilitation technologies for Chinese stroke and spinal cord injury patients.
The imaging process was developed by a team of researchers from Northwestern University and could help lead to the early diagnosis of disease.
The donor-derived cell-free DNA test was developed by the National Institutes of Health/National Heart Blood and Lung Institute.